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INTRODUCTION
Paravalvular leak (PVL) has been described as the Achilles' heel of trans-catheter aortic valve replacement (TAVR). Moderate or greater degree of PVL has been clearly associated with increased mortality, and some studies have even shown an association between mild PVL and all-cause mortality [1] [2] [3] . What happens to PVL during the follow-up period is a matter of debate. Early experience with TAVR raised the concern that progression of PVL could lead to volume overload of the left ventricle resulting in heart failure symptoms or hemolysis and consequent blood transfusion necessitating re-intervention. In the first PARTNER trial, which used the first-generation SAPIEN valve (Edwards Lifesciences Inc., Irvine, CA), PVL had worsened by C1 grade at 2 years of follow-up in 22.4% of patients [1, 2] . Like other vascular scaffolds, such as coronary stents, the supporting stent scaffold of the TAVR valves is subject to acute and late recoil, and late recoil has been postulated as a potential mechanism of progression of PVL; however, this mechanism
has not yet been described in the literature.
CASE REPORT
A 79-year-old man with a history of hypertension, diabetes, prior coronary bypass, Video 2). Acute valve recoil was re-measured and the valve had -1.1 mm (4%) recoil at the higher level, -1.02 mm (3.75%) recoil at the mid-level, and -0.14 mm (0.52%) recoil at the lower level (Fig. 1c) . Nine months later, a trans-thoracic echocardiography performed for atypical chest pain showed moderate to severe PVL and possible aortic migration of the valve (Enhanced Content Video 3). The patient was brought back for the treatment of PVL which was suspected to be due to valve migration.
Trans-esophageal echocardiography confirmed severe PVL and showed three separate regurgitation jets in the mid-esophageal short-axis view (lower left inset of Video 4 in Enhanced Content). However, fluoroscopy and trans-esophageal echocardiography showed good valve position and no evidence of valve migration (Fig. 2, Video 4) . To discover the mechanism for PVL progression we decided to measure the amount of late recoil. To this end, we obtained three angiographic cine images in the coplanar view, in the same projection that the initial TAVR had been performed. Valve diameters were measured at three levels from these films and averaged (Fig. 1d) . Late recoil was calculated by subtracting the average numbers at each level from valve diameters after balloon deflation at the post-dilation phase of the initial TAVR (middle table in Fig. 1c ). Late recoil was measured to be -0.91 mm (3.45%) at the higher level, -1.44 mm (5.5%) at the mid-level, and -1.74 mm (6.55%) at the lower level of the valve (Fig. 1d ). Therefore, the lower level of the valve showed the greatest amount of late recoil, which in our opinion was the mechanism for progression of the PVL. The summation of acute and late recoil at 12 months was Informed consent was obtained from the patient for receiving treatment.
DISCUSSION
The incidence of PVL has been reduced significantly as a result of more accurate valve sizing based on computed tomography measurements, availability of the 29-mm valve in addition to the 23-mm valve, and the 26-mm valve as a third size option, improved operators' skills, and innovative valve designs. The upshot of studies that have reported degree of PVL at different follow-up points is that the incidence of moderate or greater PVL decreases during the follow-up period in most patients [4] . The reduction in incidence of moderate or greater PVL in the follow-up could be due to increased mortality of patients who had or developed moderate to severe PVL or it could be related to remodeling of the aortic valve annulus. [5] . In Cohort B of the PARTNER II trial, which compared SAPIEN XT to the first-generation SAPIEN valve in inoperable patients, the reported incidence of moderate to severe PVL with the SAPIEN XT valve was markedly higher than that reported in other studies-24.2% at 30 days of follow-up and 27.5% at 1 year [6] . The higher rate of PVL in that study was speculated to be due to the ambiguity and difficulty in quantifying PVL and the tendency of the echocardiography core laboratory to overestimate its amount. It has however been postulated that acute and late recoil are at least partially responsible for the development and progression of PVL.
To date, only two studies have systemically assessed acute recoil of the Edwards balloon-expandable valves. Both studies only included the first-generation SAPIEN valve and the second-generation SAPIEN XT valve, and both reported higher degree of acute recoil with the SAPIEN XT valve [7, 8] . depending on the valve size or the study [7, 8] . This case report shows late recoil as the likely mechanism for progression of PVL during follow-up after a 26-mm SAPIEN XT implantation and in summation shows 7.07-9.25% of acute plus late recoil at different valve levels at 1 year of follow-up.
The effect of valve recoil on PVL has not been previously studied. Future studies need to systematically evaluate and report acute and late recoil and how they affect PVL. responsibility for the integrity of the work as a whole, and have given final approval for the version to be published. 
